Skip to content

8-KAccepted Nov 26, 6:01 AM ET

Revance Therapeutics, Inc. 8-K

Revance Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

6:01 AM

Nov 26, 2024

Filed

Nov 26, 2024

Documents

13

Size

194.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.